Giuseppe Biondi Zoccai

Pubblicazioni

Titolo Pubblicato in Anno
How to fill the GAPS-I in secondary prevention: application of a strategy based on GLP1 analogues, antithrombotic agents, PCSK9 inhibitors, SGLT2 inhibitors and immunomodulators PANMINERVA MEDICA 2022
Transcatheter aortic valve implantation with the novel-generation Navitor device. Procedural and early outcomes CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS 2022
Challenges of redo cardiac surgery. forewarned is forearmed JOURNAL OF CARDIOVASCULAR MEDICINE 2022
Surgery in severe valvular heart diseases: when it is too late. too early or right on time JOURNAL OF CARDIOVASCULAR MEDICINE 2022
Comparative effects of guided vs. potent P2Y(12) inhibitor therapy in acute coronary syndrome. A network meta-analysis of 61 898 patients from 15 randomized trials EUROPEAN HEART JOURNAL 2022
Reduction in emergency access for acute myocardial infarction during the COVID-19 pandemic: a survey from the greater area of Rome MINERVA CARDIOLOGY AND ANGIOLOGY 2022
Clinical use of cangrelor: a real-world multicenter experience from South Italy PANMINERVA MEDICA 2022
Implantation of one, two or multiple MitraClip™ for transcatheter mitral valve repair: insights from a 1824-patient multicenter study PANMINERVA MEDICA 2022
Commissural Alignment With New-Generation Self-Expanding Transcatheter Heart Valves During Aortic Replacement CARDIOVASCULAR REVASCULARIZATION MEDICINE 2022
Differential Impact of Type 1 and Type 2 Diabetes Mellitus on Outcomes Among 1.4 Million US Patients Undergoing Percutaneous Coronary Intervention CARDIOVASCULAR REVASCULARIZATION MEDICINE 2022
European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY 2022
Cardiovascular medicine: a year in review MINERVA CARDIOLOGY AND ANGIOLOGY 2022
Prognostic value of 12-leads admission electrocardiogram in low-risk patients hospitalized for COVID-19 MINERVA MEDICA 2022
Targeting the NLRP3 inflammasome in cardiovascular diseases PHARMACOLOGY & THERAPEUTICS 2022
Efficacy of new medical therapies in patients with heart failure, reduced ejection fraction, and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysis EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY 2022
Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox? JOURNAL OF THROMBOSIS AND THROMBOLYSIS 2021
Of Size and Men: A Call for Larger Trials and Meta-Analyses on Vasopressors During General Anesthesia JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA 2021
The best way to transcatheter aortic valve implantation: From standard to new approaches INTERNATIONAL JOURNAL OF CARDIOLOGY 2021
Assessing the Best Prognostic Score for Transcatheter Aortic Valve Implantation (from the RISPEVA Registry) THE AMERICAN JOURNAL OF CARDIOLOGY 2021
Renin-Angiotensin Blocking Therapies: A Must-But How?-After Percutaneous Coronary Intervention JOURNAL OF CARDIOVASCULAR PHARMACOLOGY 2021

ERC

  • LS4_1
  • LS4_2
  • LS4_10
  • LS7_14

KET

  • Big data & computing
  • Life-science technologies & biotechnologies

Interessi di ricerca

Coronary artery disease; COVID-19; Data science; Heart failure; Meta-analysis; Structural heart disease

Keywords

coronary artery diseas
percutaneous coronary revascularizatio
clinical trial
aortic diseases
left main coronary arter

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma